Discontinuation report APO-ATORVASTATIN
Report ID | 60285 |
Drug Identification Number | 02295318 |
Brand name | APO-ATORVASTATIN |
Common or Proper name | ATORVASTATIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90 BTL |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-12-28 |
Remaining supply date | 2018-12-28 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-12-29 | English | Compare |
v9 | 2018-12-28 | French | Compare |
v8 | 2018-12-28 | English | Compare |
v7 | 2018-12-28 | English | Compare |
v6 | 2018-12-28 | English | Compare |
v5 | 2018-12-28 | English | Compare |
v4 | 2018-12-13 | French | Compare |
v3 | 2018-12-13 | English | Compare |
v2 | 2018-09-07 | French | Compare |
v1 | 2018-09-07 | English | Compare |
Showing 1 to 10 of 10